ALBANY, N.Y., Dec. 19, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 second quarter financial results on Thursday, January 3, 2013, after the close of the U.S. financial markets.
Management will host an investment community conference call beginning at 4:30 p.m. Eastern Time on January 3, 2013, to discuss the results and to answer questions.
To participate in the live call by telephone, please dial 1-877-941-0844.Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' website at http://investors.angiodynamics.com . To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the website. About AngioDynamics AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com . Trademarks AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Investor Relations Contacts: EVC Group, Inc. Jamar Ismail/Robert Jones (415) 568-9348; (646) 201-5447 firstname.lastname@example.org; email@example.com Media Contact: EVC Group, Inc. Chris Gale (646) 201-5431 firstname.lastname@example.org
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts